Stellungnahme der Ad-hoc-Kommission In-vitro-Diagnostika der AWMF zur Umsetzung der Verordnung (EU) 2017/746 (IVDR) im Hinblick auf In-vitro-Diagnostika aus Eigenherstellung
GMS Zeitschrift zur Förderung der Qualitätssicherung in medizinischen Laboratorien; 12:Doc02 · 25.05.2021 · 1-1
DOI: 10.3205/lab000043 ↗Kurz gefasst
Fachartikel in der Zeitschrift GMS Zeitschrift zur Förderung der Qualitätssicherung in medizinischen Laboratorien; 12:Doc02, erschienen am 25.05.2021. Verfasst von Hoffmüller und 51 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
In view of the approaching application date of Regulation (EU) 2017/746 („IVDR“) and the resulting EU-wide, harmonized requirements for in vitro diagnostic medical devices (IVD) manufactured and used within European health institutions, the Ad hoc Commission IVD“ of the German Association of the Scientific Medical Societies (AWMF) takes a national position on the details of the requirements and conditions related to the use of these IVD products. The Ad hoc Commission IVD emphasizes the relevance of examination procedures developed in medical laboratories, especially in the field of orphan diseases and new diagnostic markers. The IVDR sets an adequate regulatory framework for IVD manufactured and used within health institutions as long as these requirements are fulfilled with reliability and in accordance with the current state of the art in medical laboratory sciences. At the same time, the IVDR requirements have to be regarded under a pragmatic view and in accordance with the quality management systems approved within the diffferent EU Member States. On the one hand, the mandatory requirements of the RiLiBÄK play an essential role in Germany. On the other hand, elements of voluntarily applicable international standards may support the fulfilment of product requirements for safety and performance according to Annex I of the IVDR. Both the complexity and possible solutions for the implementation of the IVDR requirements are discussed on the basis of examples such as the required documentation, performance evaluation and software validation. The Ad hoc Commission IVD recommends that, while aiming at a preferably EU-wide harmonized interpretation of the IVDR requirements, the flexibility in medical laboratory diagnostics necessary for patient care, including the use of IVDs from in-house production, should be emphasized.
Schlagwörter
Zitieren
APA
Hoffmüller, P., Vogeser, M., Brüggemann, M., Eggermann, T., Ghoreschi, K., Haase, D., Hofmann, J., Hunfeld, K.-P., Koch, K., Meisel, …, & A.-H.-K.-I.-V.-D.-D. (2021). Stellungnahme der Ad-hoc-Kommission In-vitro-Diagnostika der AWMF zur Umsetzung der Verordnung (EU) 2017/746 (IVDR) im Hinblick auf In-vitro-Diagnostika aus Eigenherstellung. GMS Zeitschrift zur Förderung der Qualitätssicherung in medizinischen Laboratorien; 12:Doc02, 1-1. https://doi.org/10.3205/lab000043
Vancouver
Hoffmüller, P., Vogeser, M., Brüggemann, M., et al. Stellungnahme der Ad-hoc-Kommission In-vitro-Diagnostika der AWMF zur Umsetzung der Verordnung (EU) 2017/746 (IVDR) im Hinblick auf In-vitro-Diagnostika aus Eigenherstellung. GMS Zeitschrift zur Förderung der Qualitätssicherung in medizinischen Laboratorien; 12:Doc02. 2021:1-1. doi:10.3205/lab000043
BibTeX
@article{Hoffmller2021,
author = {Hoffmüller and P. and Vogeser and M. and Brüggemann and M. and Eggermann and T. and Ghoreschi and K. and Haase and D. and Hofmann and J. and Hunfeld and K.-P. and Koch and K. and Meisel and C. and Michl and P. and Müller and J. and Müller and C. and Rabenau and H.-F. and Reinhardt and D. and Riemenschneider and M.-J. and Sachs and U.-J. and Sack and U. and Stenzinger and A. and Streichert and T. and Neuhoff, von and N. and Weichert and W. and Weinstock and C. and Zimmermann and S. and Spitzenberger and F. and AWMF and A.-H.-K.-I.-V.-D.-D.},
title = {Stellungnahme der Ad-hoc-Kommission In-vitro-Diagnostika der AWMF zur Umsetzung der Verordnung (EU) 2017/746 (IVDR) im Hinblick auf In-vitro-Diagnostika aus Eigenherstellung},
journal = {GMS Zeitschrift zur Förderung der Qualitätssicherung in medizinischen Laboratorien; 12:Doc02},
year = {2021},
pages = {1--1},
doi = {10.3205/lab000043}
}
EUVIMED